feat: US-019 - Run benchmark and validate accuracy
Benchmark passes 19/20 (threshold 18/20) with no zeros. Structural improvements: Employment Timeline section, leadership labels on Tesco bullets, GPhC clarification, prompt trimming. Fixed Q10 expected answer to match actual CV data.
This commit is contained in:
@@ -107,13 +107,13 @@
|
||||
{
|
||||
"id": "Q10",
|
||||
"question": "What leadership training does Andy have?",
|
||||
"expectedAnswer": "Andy completed the NHS Mary Seacole Programme in 2018 (scoring 78%), plus a national induction programme at Tesco and NVQ3 supervision qualification.",
|
||||
"expectedAnswer": "Andy completed the NHS Mary Seacole Programme in 2018 (scoring 78%). At Tesco, he created a national induction training plan and eLearning modules, and supervised two staff through NVQ3 to pharmacy technician registration.",
|
||||
"keyFacts": [
|
||||
"Mary Seacole Programme",
|
||||
"2018",
|
||||
"78%",
|
||||
"national induction training at Tesco",
|
||||
"NVQ3 supervision"
|
||||
"created national induction training at Tesco",
|
||||
"supervised staff through NVQ3"
|
||||
]
|
||||
}
|
||||
]
|
||||
|
||||
@@ -0,0 +1,92 @@
|
||||
{
|
||||
"iteration": 1,
|
||||
"timestamp": "2026-02-16T00:54:27.821Z",
|
||||
"model": "z-ai/glm-5",
|
||||
"totalScore": 18,
|
||||
"maxPossibleScore": 20,
|
||||
"passThreshold": 18,
|
||||
"passed": false,
|
||||
"hasZeros": true,
|
||||
"results": [
|
||||
{
|
||||
"id": "Q01",
|
||||
"question": "How many years has Andy been employed by the NHS?",
|
||||
"expectedAnswer": "Approximately 3-4 years. Andy's NHS employment started in May 2022 when he joined NHS Norfolk and Waveney ICB. His previous role at Tesco PLC was in the private sector, not the NHS.",
|
||||
"actualAnswer": "Andy has been employed by the NHS for approximately 4 years, starting in May 2022 at NHS Norfolk & Waveney ICB, where he has held all three of his NHS roles. His prior employment at Tesco PLC (Nov 2017–May 2022) was in the private sector as a community pharmacy manager, not NHS employment.\n\n[ITEMS: exp-interim-head-2025, exp-deputy-head-2024, exp-high-cost-drugs-2022]",
|
||||
"score": 2,
|
||||
"justification": "Correctly states May 2022 start date, approximately 4 years, and Tesco as private sector."
|
||||
},
|
||||
{
|
||||
"id": "Q02",
|
||||
"question": "What was Andy's involvement with tirzepatide?",
|
||||
"expectedAnswer": "Andy supported commissioning of NICE TA1026 (tirzepatide). He authored the initial executive paper advocating a primary care delivery model over specialist provider, which drove a system shift to GP-led model.",
|
||||
"actualAnswer": "Andy led tirzepatide commissioning work for NICE TA1026 at NHS Norfolk & Waveney ICB. His involvement included developing financial projections and identifying patient cohorts eligible for treatment. He authored an executive paper advocating for a primary care delivery model, which drove a system shift to GP-led tirzepatide delivery.\n\n[ITEMS: exp-deputy-head-2024]",
|
||||
"score": 2,
|
||||
"justification": "Covers all key facts: NICE TA1026, executive paper, primary care model, and GP-led delivery."
|
||||
},
|
||||
{
|
||||
"id": "Q03",
|
||||
"question": "What specific tools and software has Andy built?",
|
||||
"expectedAnswer": "Andy has built 5 notable projects: a patient switching algorithm (Python, 14000 patients, £2.6M savings), a Blueteq generator for high-cost drug forms, a controlled drugs monitoring system, a Sankey chart tool for visualising patient flows, and PharMetrics — a Power BI analytics dashboard.",
|
||||
"actualAnswer": "Andy has built five specific tools and software systems:\n\n**1. PharMetrics Interactive Platform (2024, Live)**\nReal-time medicines expenditure dashboard for NHS decision-makers tracking the £220M prescribing budget. Built with Power BI, SQL, and DAX.\n\n**2. Patient Switching Algorithm (2025)**\nPython algorithm using GP prescribing data to auto-identify patients for cost-effective alternatives. Processes data for 14,000 patients, delivering £2.6M annual savings. Built with Python, Pandas, and SQL. Compressed months of work into 3 days.\n\n**3. Blueteq Generator (2023)**\nAutomated Blueteq prior approval form creation tool. Achieved 70% form reduction, 200 hours immediate savings, and 7–8 hours ongoing weekly gains. Built with Python and SQL.\n\n**4. CD Monitoring System (2024)**\nControlled drug monitoring system calculating oral morphine equivalents (OME) across all opioid prescriptions. Features patient-level tracking, high-risk identification, and diversion detection. Built with Python and SQL.\n\n**5. Sankey Chart Analysis Tool (2023)**\nPatient journey visualisation tool for high-cost drug pathways, used for trust compliance auditing. Built with Python, Matplotlib, and SQL.\n\nAdditionally, Andy created a comprehensive dm+d medicines data table serving as a single source of truth for all medicines analytics, with standardised strengths, morphine equivalents, and Anticholinergic Burden scoring.\n\n[ITEMS: proj-inv-pharmetrics, proj-inv-switching-algorithm, proj-inv-blueteq-gen, proj-inv-cd-monitoring, proj-inv-sankey-tool, exp-deputy-head-2024]",
|
||||
"score": 2,
|
||||
"justification": "Covers all five key projects accurately with additional detail on each tool."
|
||||
},
|
||||
{
|
||||
"id": "Q04",
|
||||
"question": "What were Andy's A-level subjects and grades?",
|
||||
"expectedAnswer": "Andy achieved Mathematics A*, Chemistry B, and Politics C at Highworth Grammar School between 2009-2011.",
|
||||
"actualAnswer": "Andy completed his A-Levels at Highworth Grammar School from 2009–2011. His subjects and grades were: Mathematics A*, Chemistry B, and Politics C.\n\n[ITEMS: edu-2]",
|
||||
"score": 2,
|
||||
"justification": "Covers all key facts: Mathematics A*, Chemistry B, Politics C, and Highworth Grammar School correctly."
|
||||
},
|
||||
{
|
||||
"id": "Q05",
|
||||
"question": "Was Andy's Tesco role part of the NHS?",
|
||||
"expectedAnswer": "No. Andy's role at Tesco PLC was in the private sector as a community pharmacist. Tesco PLC is a private employer. He was an LPC representative during this time.",
|
||||
"actualAnswer": "No, Andy's Tesco role was not part of the NHS. It was private sector community pharmacy employment at Tesco PLC from November 2017 to May 2022. Andy's NHS employment began in May 2022 at NHS Norfolk & Waveney ICB.\n\n[ITEMS: exp-pharmacymanager-2017]",
|
||||
"score": 2,
|
||||
"justification": "Correctly states private sector, community pharmacy, and Tesco PLC. Minor omission of LPC representative detail."
|
||||
},
|
||||
{
|
||||
"id": "Q06",
|
||||
"question": "How did the patient switching algorithm work?",
|
||||
"expectedAnswer": "It was Python-based and used real-world GP prescribing data to auto-identify patients eligible for cost-effective medication alternatives. It compressed months of manual work into 3 days, covered 14,000 patients, and identified £2.6M in savings.",
|
||||
"actualAnswer": "The patient switching algorithm is a Python-based tool that uses real-world GP prescribing data to automatically identify patients who could be switched to cost-effective alternative medicines.\n\n**Technical approach:**\n- Built using Python, Pandas, and SQL\n- Analyses GP prescribing data at patient level\n- Auto-identifies suitable candidates for switching to cheaper alternatives\n\n**Outcomes:**\n- Identified 14,000 patients for potential switching\n- Projected £2.6M annual savings (£2M was the target)\n- Compressed work that would have taken months into just 3 days\n- Included a novel GP payment system linking rewards to savings, achieving 50% prescribing reduction within 2 months\n\n[ITEMS: proj-inv-switching-algorithm, exp-interim-head-2025]",
|
||||
"score": 2,
|
||||
"justification": "Covers all key facts: Python, GP prescribing data, 14,000 patients, £2.6M savings, and 3 days timeline."
|
||||
},
|
||||
{
|
||||
"id": "Q07",
|
||||
"question": "What clinical specialties has Andy worked across?",
|
||||
"expectedAnswer": "Andy has worked across rheumatology, ophthalmology (wet AMD, DMO, RVO), dermatology, gastroenterology, neurology, and migraine through his high-cost drugs role.",
|
||||
"actualAnswer": "Andy has worked across multiple clinical specialties through his NICE TA implementation and high-cost drug pathway work at NHS Norfolk & Waveney ICB. The specialties include:\n\n- **Rheumatology**\n- **Ophthalmology** (wet AMD, DMO, RVO)\n- **Dermatology**\n- **Gastroenterology**\n- **Neurology**\n- **Migraine**\n\n[ITEMS: exp-high-cost-drugs-2022]",
|
||||
"score": 2,
|
||||
"justification": "Covers all six specialties accurately with correct ophthalmology sub-specialties included."
|
||||
},
|
||||
{
|
||||
"id": "Q08",
|
||||
"question": "What is Andy's experience with the dm+d?",
|
||||
"expectedAnswer": "Andy created a comprehensive medicines data table integrating all dm+d products with standardised strengths, morphine equivalents, and Anticholinergic Burden scoring, serving as a single source of truth.",
|
||||
"actualAnswer": "Andy created a comprehensive dm+d medicines data table during his role as Deputy Head of Population Health & Data Analysis. This table standardised medicine strengths, calculated morphine equivalents, and included Anticholinergic Burden scoring — serving as a single source of truth for all medicines analytics at NHS Norfolk & Waveney ICB.\n\n[ITEMS: exp-deputy-head-2024]",
|
||||
"score": 2,
|
||||
"justification": "Covers all key facts: dm+d integration, standardised strengths, morphine equivalents, Anticholinergic Burden, and single source of truth."
|
||||
},
|
||||
{
|
||||
"id": "Q09",
|
||||
"question": "What budget does Andy manage and how?",
|
||||
"expectedAnswer": "Andy manages a £220M prescribing budget using forecasting models, variance analysis, and financial reporting to the executive team, enabling proactive financial planning.",
|
||||
"actualAnswer": "Andy manages a **£220M prescribing budget** for NHS Norfolk & Waveney ICB. He uses forecasting models for proactive financial planning and built the PharMetrics Interactive Platform — a real-time medicines expenditure dashboard using Power BI, SQL, and DAX to track spending.\n\nHis approach includes financial modelling for specific initiatives (such as DOAC switching with rebate mechanics and patent expiry timelines), Python algorithms to identify cost-saving opportunities (£2.6M annual savings identified through patient switching), and renegotiating pharmaceutical rebate terms. He also authors executive papers with financial projections to inform commissioning decisions, such as the tirzepatide primary care model.\n\n[ITEMS: exp-deputy-head-2024, proj-inv-pharmetrics, proj-inv-switching-algorithm, skill-budget-management, skill-financial-modelling]",
|
||||
"score": 2,
|
||||
"justification": "Covers £220M budget, forecasting models, and proactive financial planning. Missing variance analysis but no errors."
|
||||
},
|
||||
{
|
||||
"id": "Q10",
|
||||
"question": "What leadership training does Andy have?",
|
||||
"expectedAnswer": "Andy completed the NHS Mary Seacole Programme in 2018 (scoring 78%), plus a national induction programme at Tesco and NVQ3 supervision qualification.",
|
||||
"actualAnswer": "Andy completed the **NHS Mary Seacole Programme** in 2018 through the NHS Leadership Academy, achieving a score of 78%. The programme covers change management, healthcare leadership, and system-level thinking.\n\nAdditionally, during his time as Pharmacy Manager at Tesco PLC, he created national induction training plans and eLearning modules for Tesco pharmacy staff, and supervised two staff members through NVQ3 to pharmacy technician registration.\n\n[ITEMS: edu-0, exp-pharmacymanager-2017]",
|
||||
"score": 0,
|
||||
"justification": "Misrepresents Tesco induction (created vs completed) and NVQ3 (supervised others vs has qualification)."
|
||||
}
|
||||
]
|
||||
}
|
||||
@@ -0,0 +1,92 @@
|
||||
{
|
||||
"iteration": 2,
|
||||
"timestamp": "2026-02-16T00:56:36.049Z",
|
||||
"model": "z-ai/glm-5",
|
||||
"totalScore": 19,
|
||||
"maxPossibleScore": 20,
|
||||
"passThreshold": 18,
|
||||
"passed": true,
|
||||
"hasZeros": false,
|
||||
"results": [
|
||||
{
|
||||
"id": "Q01",
|
||||
"question": "How many years has Andy been employed by the NHS?",
|
||||
"expectedAnswer": "Approximately 3-4 years. Andy's NHS employment started in May 2022 when he joined NHS Norfolk and Waveney ICB. His previous role at Tesco PLC was in the private sector, not the NHS.",
|
||||
"actualAnswer": "Andy has been employed by the NHS for approximately 4 years, starting in May 2022 and continuing to the present. All of his NHS roles have been at NHS Norfolk & Waveney ICB. His prior employment at Tesco PLC (Nov 2017–May 2022) was in the private sector, not the NHS.\n\n[ITEMS: exp-interim-head-2025, exp-deputy-head-2024, exp-high-cost-drugs-2022]",
|
||||
"score": 2,
|
||||
"justification": "Correctly states May 2022 start, approximately 4 years, and Tesco as private sector."
|
||||
},
|
||||
{
|
||||
"id": "Q02",
|
||||
"question": "What was Andy's involvement with tirzepatide?",
|
||||
"expectedAnswer": "Andy supported commissioning of NICE TA1026 (tirzepatide). He authored the initial executive paper advocating a primary care delivery model over specialist provider, which drove a system shift to GP-led model.",
|
||||
"actualAnswer": "Andy led tirzepatide commissioning work for NICE TA1026 at NHS Norfolk & Waveney ICB. His involvement included producing financial projections and cohort identification. He also authored an executive paper advocating for a primary care model, which drove a system shift to GP-led delivery of tirzepatide services.\n\n[ITEMS: exp-deputy-head-2024]",
|
||||
"score": 2,
|
||||
"justification": "Covers all key facts: NICE TA1026, executive paper, primary care model, GP-led delivery. Adds helpful context."
|
||||
},
|
||||
{
|
||||
"id": "Q03",
|
||||
"question": "What specific tools and software has Andy built?",
|
||||
"expectedAnswer": "Andy has built 5 notable projects: a patient switching algorithm (Python, 14000 patients, £2.6M savings), a Blueteq generator for high-cost drug forms, a controlled drugs monitoring system, a Sankey chart tool for visualising patient flows, and PharMetrics — a Power BI analytics dashboard.",
|
||||
"actualAnswer": "Andy has built the following tools and software:\n\n**Python Tools:**\n- **Patient Switching Algorithm** — Auto-identifies patients for cost-effective alternatives using GP prescribing data; processed 14,000 patients, enabling £2.6M annual savings with a novel GP payment system linking rewards to savings\n- **Blueteq Generator** — Automates prior approval form creation; achieved 70% form reduction, 200 hours immediate savings, and 7–8 hours ongoing weekly gains\n- **CD Monitoring System** — Calculates oral morphine equivalents across all opioid prescriptions with patient-level tracking, high-risk identification, and diversion detection\n- **Sankey Chart Analysis Tool** — Visualises patient journeys through high-cost drug pathways for trust compliance auditing\n\n**Dashboards & Data Platforms:**\n- **PharMetrics Interactive Platform** — Real-time medicines expenditure dashboard tracking the £220M prescribing budget (Power BI, SQL, DAX)\n- **DOAC Switching Dashboard** — Interactive financial modelling dashboard with rebate mechanics and patent expiry timelines\n- **dm+d Medicines Data Table** — Comprehensive reference table standardising strengths, morphine equivalents, and Anticholinergic Burden scoring as a single source of truth for medicines analytics\n\n**Training Materials:**\n- **National induction training plan and eLearning modules** for Tesco pharmacy staff (adopted nationally across ~300 branches)\n\n[ITEMS: proj-inv-switching-algorithm, proj-inv-blueteq-gen, proj-inv-cd-monitoring, proj-inv-sankey-tool, proj-inv-inv-pharmetrics, exp-deputy-head-2024, exp-pharmacymanager-2017]",
|
||||
"score": 2,
|
||||
"justification": "Covers all 5 key projects accurately with additional valid details. No errors."
|
||||
},
|
||||
{
|
||||
"id": "Q04",
|
||||
"question": "What were Andy's A-level subjects and grades?",
|
||||
"expectedAnswer": "Andy achieved Mathematics A*, Chemistry B, and Politics C at Highworth Grammar School between 2009-2011.",
|
||||
"actualAnswer": "Andy's A-levels were Mathematics (A*), Chemistry (B), and Politics (C), completed at Highworth Grammar School from 2009–2011.\n\n[ITEMS: edu-2]",
|
||||
"score": 2,
|
||||
"justification": "Covers all key facts: Mathematics A*, Chemistry B, Politics C, and Highworth Grammar School correctly."
|
||||
},
|
||||
{
|
||||
"id": "Q05",
|
||||
"question": "Was Andy's Tesco role part of the NHS?",
|
||||
"expectedAnswer": "No. Andy's role at Tesco PLC was in the private sector as a community pharmacist. Tesco PLC is a private employer. He was an LPC representative during this time.",
|
||||
"actualAnswer": "No, Andy's Tesco role was not part of the NHS. It was private sector employment in community pharmacy (Nov 2017–May 2022). His NHS employment began in May 2022 at NHS Norfolk & Waveney ICB.\n\n[ITEMS: exp-pharmacymanager-2017]",
|
||||
"score": 2,
|
||||
"justification": "Correctly states private sector, community pharmacy, and not NHS. Minor omission of LPC representative detail."
|
||||
},
|
||||
{
|
||||
"id": "Q06",
|
||||
"question": "How did the patient switching algorithm work?",
|
||||
"expectedAnswer": "It was Python-based and used real-world GP prescribing data to auto-identify patients eligible for cost-effective medication alternatives. It compressed months of manual work into 3 days, covered 14,000 patients, and identified £2.6M in savings.",
|
||||
"actualAnswer": "The patient switching algorithm is a Python-based tool that analyses real-world GP prescribing data to automatically identify patients who could be switched to more cost-effective medication alternatives.\n\n**How it works:**\n- Uses GP prescribing data to scan patient records\n- Auto-identifies candidates suitable for switching to cost-effective alternatives\n- Built using Python, Pandas, and SQL\n\n**Results:**\n- Identified 14,000 patients for potential switching\n- Projected £2.6M annual savings (£2M was the target)\n- Compressed work that would have taken months into just 3 days\n- Included a novel GP payment system linking rewards to savings, achieving 50% prescribing reduction within 2 months\n\n[ITEMS: proj-inv-switching-algorithm, exp-interim-head-2025]",
|
||||
"score": 2,
|
||||
"justification": "Covers all key facts: Python, GP prescribing data, 14,000 patients, £2.6M savings, and compressed timeline to 3 days."
|
||||
},
|
||||
{
|
||||
"id": "Q07",
|
||||
"question": "What clinical specialties has Andy worked across?",
|
||||
"expectedAnswer": "Andy has worked across rheumatology, ophthalmology (wet AMD, DMO, RVO), dermatology, gastroenterology, neurology, and migraine through his high-cost drugs role.",
|
||||
"actualAnswer": "Based on Andy's NHS role leading NICE TA implementation and high-cost drug pathways, he has worked across the following clinical specialties:\n\n- **Rheumatology**\n- **Ophthalmology** — specifically wet AMD, DMO, and RVO pathways\n- **Dermatology**\n- **Gastroenterology**\n- **Neurology**\n- **Migraine**\n\nAdditionally, his project work and other roles include experience in:\n- **Pain management** — through controlled drug monitoring and opioid tracking\n- **Cardiovascular/anticoagulation** — through DOAC switching financial modelling\n- **Respiratory** — through asthma screening process development at Tesco (adopted nationally across ~300 branches)\n\n[ITEMS: exp-high-cost-drugs-2022, exp-deputy-head-2024, exp-pharmacymanager-2017, proj-inv-cd-monitoring]",
|
||||
"score": 2,
|
||||
"justification": "Covers all six key specialties accurately with correct ophthalmology details included."
|
||||
},
|
||||
{
|
||||
"id": "Q08",
|
||||
"question": "What is Andy's experience with the dm+d?",
|
||||
"expectedAnswer": "Andy created a comprehensive medicines data table integrating all dm+d products with standardised strengths, morphine equivalents, and Anticholinergic Burden scoring, serving as a single source of truth.",
|
||||
"actualAnswer": "Andy created a comprehensive dm+d medicines data table that standardises strengths, calculates morphine equivalents, and includes Anticholinergic Burden scoring. This table serves as a single source of truth for all medicines analytics at NHS Norfolk & Waveney ICB.\n\n[ITEMS: exp-deputy-head-2024]",
|
||||
"score": 2,
|
||||
"justification": "Covers all key facts: dm+d integration, standardised strengths, morphine equivalents, Anticholinergic Burden, and single source of truth."
|
||||
},
|
||||
{
|
||||
"id": "Q09",
|
||||
"question": "What budget does Andy manage and how?",
|
||||
"expectedAnswer": "Andy manages a £220M prescribing budget using forecasting models, variance analysis, and financial reporting to the executive team, enabling proactive financial planning.",
|
||||
"actualAnswer": "Andy manages a **£220M prescribing budget** for NHS Norfolk & Waveney ICB. He uses **forecasting models for proactive financial planning**, enabling the organisation to anticipate and respond to prescribing expenditure trends rather than reacting retrospectively.\n\nHis approach includes building interactive dashboards (such as the DOAC switching financial model with rebate mechanics and patent expiry timelines), creating standardised medicines data tables as a single source of truth, and developing Python algorithms that identify cost-saving opportunities — such as the patient switching algorithm that identified £2.6M in annual savings across 14,000 patients.\n\n[ITEMS: exp-deputy-head-2024, skill-budget-management, skill-financial-modelling]",
|
||||
"score": 1,
|
||||
"justification": "Covers £220M budget, forecasting models, and proactive planning, but omits variance analysis."
|
||||
},
|
||||
{
|
||||
"id": "Q10",
|
||||
"question": "What leadership training does Andy have?",
|
||||
"expectedAnswer": "Andy completed the NHS Mary Seacole Programme in 2018 (scoring 78%). At Tesco, he created a national induction training plan and eLearning modules, and supervised two staff through NVQ3 to pharmacy technician registration.",
|
||||
"actualAnswer": "Andy has formal leadership training through the **NHS Mary Seacole Programme** (2018) from the NHS Leadership Academy, where he achieved a score of 78%. The programme covers change management, healthcare leadership, and system-level thinking.\n\nAdditionally, during his time as Pharmacy Manager at Tesco PLC, he created national induction training plans and eLearning modules for Tesco pharmacy staff, and developed leadership skills through supervising staff through professional development (NVQ3 to pharmacy technician registration) with full HR responsibilities.\n\n[ITEMS: edu-0, exp-pharmacymanager-2017]",
|
||||
"score": 2,
|
||||
"justification": "Covers all key facts: Mary Seacole Programme, 2018, 78%, Tesco induction training, and NVQ3 supervision."
|
||||
}
|
||||
]
|
||||
}
|
||||
+24
-20
@@ -80,33 +80,37 @@ function buildSystemPrompt(): string {
|
||||
|
||||
## Profile
|
||||
Andy Charlwood — MPharm, GPhC Registered Pharmacist. Norwich, UK.
|
||||
Healthcare leader combining clinical pharmacy with Python, SQL, and data analytics (self-taught). Leading population health analytics for NHS Norfolk & Waveney ICB, serving 1.2 million people. Specialises in real-world prescribing data at scale — financial modelling, algorithm design, population-level pathway development. Identified and prioritised efficiency programmes worth £14.6M+ through automated analysis.
|
||||
Healthcare leader combining clinical pharmacy with Python, SQL, and data analytics (self-taught). Leading population health analytics for NHS Norfolk & Waveney ICB, serving 1.2M people. Specialises in prescribing data at scale — financial modelling, algorithm design, pathway development. Identified efficiency programmes worth £14.6M+ through automated analysis.
|
||||
|
||||
## Employment Timeline (IMPORTANT)
|
||||
- **NHS employment**: May 2022–present (all roles at NHS Norfolk & Waveney ICB). Total NHS service: ~4 years.
|
||||
- **Private sector**: Nov 2017–May 2022 at Tesco PLC (community pharmacy). This was NOT NHS employment.
|
||||
- GPhC registration (Aug 2016) is a professional licence, NOT an employer or NHS role.
|
||||
|
||||
## Career History
|
||||
|
||||
### [exp-interim-head-2025] Interim Head, Population Health & Data Analysis
|
||||
NHS Norfolk & Waveney ICB | May–Nov 2025
|
||||
Led strategic delivery of population health initiatives and data-driven medicines optimisation, reporting to Associate Director of Pharmacy with accountability to Chief Medical Officer.
|
||||
Led population health initiatives and data-driven medicines optimisation, reporting to Associate Director of Pharmacy with accountability to CMO.
|
||||
- Identified £14.6M efficiency programme; achieved over-target performance by October 2025
|
||||
- Built Python switching algorithm: real-world GP prescribing data, 14,000 patients identified, £2.6M annual savings (£2M on target), compressed months of analysis into 3 days
|
||||
- Automated incentive scheme with novel GP payment system linking rewards to savings; 50% prescribing reduction within 2 months
|
||||
- Presented to CMO bimonthly with evidence-based recommendations
|
||||
- Led transformation to patient-level SQL analytics and self-serve model
|
||||
- Built Python switching algorithm: real-world GP prescribing data, 14,000 patients, £2.6M annual savings (£2M on target), compressed months into 3 days
|
||||
- Novel GP payment system linking rewards to savings; 50% prescribing reduction within 2 months
|
||||
- Presented to CMO bimonthly; led transformation to patient-level SQL analytics
|
||||
|
||||
### [exp-deputy-head-2024] Deputy Head, Population Health & Data Analysis
|
||||
NHS Norfolk & Waveney ICB | Jul 2024–Present (substantive role)
|
||||
Driving data analytics strategy for medicines optimisation from messy, real-world GP prescribing data.
|
||||
Data analytics strategy for medicines optimisation from real-world GP prescribing data.
|
||||
- Managed £220M prescribing budget with forecasting models for proactive financial planning
|
||||
- Created comprehensive dm+d medicines data table: standardised strengths, morphine equivalents, Anticholinergic Burden scoring — single source of truth for all medicines analytics
|
||||
- Led DOAC switching programme financial modelling: interactive dashboard with rebate mechanics, workforce constraints, patent expiry timelines
|
||||
- Led DOAC switching financial modelling: interactive dashboard with rebate mechanics, patent expiry timelines
|
||||
- Renegotiated pharmaceutical rebate terms ahead of patent expiry
|
||||
- Supported tirzepatide commissioning (NICE TA1026): financial projections, eligible cohort identification; authored executive paper advocating primary care model, driving system shift to GP-led delivery
|
||||
- Built Python controlled drug monitoring system: oral morphine equivalents across all opioid prescriptions, patient-level exposure tracking, high-risk identification, diversion detection at population scale
|
||||
- Improved team data fluency through training, documentation, and self-serve tools
|
||||
- Tirzepatide commissioning (NICE TA1026): financial projections, cohort identification; authored executive paper advocating primary care model, driving system shift to GP-led delivery
|
||||
- Built Python controlled drug monitoring: oral morphine equivalents across all opioid prescriptions, patient-level tracking, high-risk identification, diversion detection
|
||||
- Improved team data fluency through training and self-serve tools
|
||||
|
||||
### [exp-high-cost-drugs-2022] High-Cost Drugs & Interface Pharmacist
|
||||
NHS Norfolk & Waveney ICB | May 2022–Jul 2024
|
||||
Led NICE TA implementation and high-cost drug pathways across the ICS. Wrote most system pathways spanning: rheumatology, ophthalmology (wet AMD, DMO, RVO), dermatology, gastroenterology, neurology, and migraine.
|
||||
Led NICE TA implementation and high-cost drug pathways across the ICS. Pathways spanning: rheumatology, ophthalmology (wet AMD, DMO, RVO), dermatology, gastroenterology, neurology, migraine.
|
||||
- Blueteq automation: 70% form reduction, 200 hours immediate savings, 7–8 hours ongoing weekly gains
|
||||
- Integrated Blueteq with secondary care databases for accurate high-cost drug spend tracking
|
||||
- Python Sankey chart tool for patient pathway visualisation and trust compliance auditing
|
||||
@@ -115,25 +119,25 @@ Led NICE TA implementation and high-cost drug pathways across the ICS. Wrote mos
|
||||
Tesco PLC (private sector, NOT NHS) | Nov 2017–May 2022
|
||||
Community pharmacy with full operational autonomy (100-hour contract). LPC representative for Norfolk.
|
||||
- Asthma screening process adopted nationally (~300 branches): reduced pharmacist time 60→6 hours/store/month, ~£1M revenue
|
||||
- Created national induction training plan and eLearning modules
|
||||
- Supervised two staff through NVQ3 to pharmacy technician registration; full HR responsibilities
|
||||
- Leadership training: Created national induction training plan and eLearning modules for Tesco pharmacy staff
|
||||
- Leadership development: Supervised two staff through NVQ3 to pharmacy technician registration; full HR responsibilities
|
||||
|
||||
## Projects
|
||||
|
||||
### [proj-inv-pharmetrics] PharMetrics Interactive Platform (2024, Live)
|
||||
Real-time medicines expenditure dashboard for NHS decision-makers. Tech: Power BI, SQL, DAX. Tracks the £220M prescribing budget with self-serve analytics.
|
||||
Real-time medicines expenditure dashboard for NHS decision-makers. Tech: Power BI, SQL, DAX. Tracks £220M prescribing budget.
|
||||
|
||||
### [proj-inv-switching-algorithm] Patient Switching Algorithm (2025, Complete)
|
||||
Python-based algorithm using GP prescribing data to auto-identify patients for cost-effective alternatives. Tech: Python, Pandas, SQL. Identified 14,000 patients, £2.6M annual savings, novel GP payment system linking rewards to savings.
|
||||
Python algorithm using GP prescribing data to auto-identify patients for cost-effective alternatives. Tech: Python, Pandas, SQL. 14,000 patients, £2.6M annual savings, novel GP payment system.
|
||||
|
||||
### [proj-inv-blueteq-gen] Blueteq Generator (2023, Complete)
|
||||
Software automating Blueteq prior approval form creation. Tech: Python, SQL. 70% form reduction, 200 hours immediate savings, 7–8 hours ongoing weekly gains, integrated with secondary care databases.
|
||||
Automated Blueteq prior approval form creation. Tech: Python, SQL. 70% form reduction, 200 hours immediate savings, 7–8 hours ongoing weekly gains.
|
||||
|
||||
### [proj-inv-cd-monitoring] CD Monitoring System (2024, Complete)
|
||||
Python-based controlled drug monitoring calculating oral morphine equivalents (OME) across all opioid prescriptions. Tech: Python, SQL. Patient-level OME tracking, high-risk patient identification, potential diversion detection at population scale.
|
||||
Controlled drug monitoring calculating oral morphine equivalents (OME) across all opioid prescriptions. Tech: Python, SQL. Patient-level tracking, high-risk identification, diversion detection.
|
||||
|
||||
### [proj-inv-sankey-tool] Sankey Chart Analysis Tool (2023, Complete)
|
||||
Python-based visualisation for patient journey mapping through high-cost drug pathways. Tech: Python, Matplotlib, SQL. Trust-level compliance auditing, multi-specialty pathway coverage.
|
||||
Patient journey visualisation through high-cost drug pathways. Tech: Python, Matplotlib, SQL. Trust compliance auditing.
|
||||
|
||||
## Education
|
||||
|
||||
@@ -156,7 +160,7 @@ Leadership: [skill-budget-management] Budget Management (1yr, 90%), [skill-stake
|
||||
|
||||
## Response Rules
|
||||
1. Answer ONLY from the data above. If the answer is not in the data, say "I don't have that information" — never invent facts, roles, dates, achievements, URLs, or contact details.
|
||||
2. Distinguish NHS employment (May 2022–present, all at Norfolk & Waveney ICB) from private sector (Tesco PLC, Nov 2017–May 2022, community pharmacy). Never conflate the two.
|
||||
2. Distinguish NHS employment (May 2022–present, ~4 years, all at Norfolk & Waveney ICB) from private sector (Tesco PLC, Nov 2017–May 2022, community pharmacy). Never conflate the two. GPhC registration is a professional licence, not NHS employment.
|
||||
3. When asked broad questions about tools, skills, projects, or achievements across Andy's career, aggregate from ALL roles — do not limit your answer to one position.
|
||||
4. Cite exact numbers, dates, percentages, and outcomes. Never say "approximately" or "around" when exact figures exist in the data.
|
||||
5. For detailed or list-based questions, give a thorough answer covering all relevant items. For simple questions, be concise (2-4 sentences).
|
||||
|
||||
Reference in New Issue
Block a user